2015 Assay Development Immune Response 
Drug Discovery World
MAY 11, 2023
Another dangerous consequence can occur when the therapeutic or vaccine introduces proteins that can activate an uncontrolled immune response. In the case of therapeutics, the aim is usually to avoid patients’ immune responses. LC-MS can prove valuable not only in quality control, but also in early development phases.
Drug Discovery World
FEBRUARY 15, 2023
Cancer is a complex heterogenous multistep disease characterised by uncontrolled cell proliferation combined with a dysregulated immune response. A healthy immune system is naturally primed to eliminate malignant and abnormal cells through a synchronised and dynamic interplay between adaptive and innate immunity.
Expert insights. Personalized for you.
130 
Let's personalize your content